HomepageBICO • STO
add
Bico Group
Vorige slotkoers
kr 34,62
Dag-range
kr 35,20 - kr 37,20
Jaar-range
kr 33,06 - kr 72,30
Beurswaarde
2,51Â mld. SEK
Gem. volume
114,31K
Koers/winst
-
Dividendrendement
-
Primaire beurs
STO
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(SEK) | jun 2024info | Wijziging j-o-j |
---|---|---|
Opbrengst | 534,00Â mln. | -0,56% |
Bedrijfskosten | 324,90Â mln. | 86,51% |
Netto inkomsten | -77,90Â mln. | 81,64% |
Netto winstmarge | -14,59 | 81,53% |
Winst per aandeel | — | — |
EBITDA | 35,50Â mln. | -93,03% |
Effectief belastingtarief | 8,49% | — |
Balans
Totale activa
Totale passiva
(SEK) | jun 2024info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 687,60Â mln. | -0,45% |
Totale activa | 5,70Â mld. | -37,50% |
Totale passiva | 2,72Â mld. | -11,43% |
Totaal aandelenvermogen | 2,97 mld. | — |
Uitstaande aandelen | 70,57 mln. | — |
Koers-boekwaardeverhouding | 0,83 | — |
Rendement op activa | -2,15% | — |
Rendement op kapitaal | -2,50% | — |
Kasstroom
Nettomutatie in liquide middelen
(SEK) | jun 2024info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | -77,90Â mln. | 81,64% |
Operationele kasstroom | -50,90Â mln. | -6,71% |
Kasstroom uit beleggingen | -22,60Â mln. | 80,11% |
Kasstroom uit financiering | -27,80Â mln. | -424,53% |
Nettomutatie in liquide middelen | -108,10Â mln. | 35,88% |
Vrije kasstroom | -91,89Â mln. | -126,44% |
Over
Bico Group is a bioconvergence startup that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting, and its products often combine capabilities in artificial intelligence, robotics, multiomics, and diagnostics.
Bico Group began by producing bio-inks and bioprinters for culturing different cell types to enable applications like patient-derived implants. Bico Group was the first company to provide a standardized bio-ink product for sale over the internet.
The company has ongoing collaborations with organizations including AstraZeneca, MedImmune, MIT and Takara Bio, and its bioprinters are used for research at Harvard University, Merck, Novartis, the U.S. Army, Toyota, Johnson & Johnson and more. Wikipedia
Opgericht
27 jan 2016
Website
Werknemers
832